Kapoor Neha, Saxena Sanjai
Department of Biotechnology, Thapar University, Patiala, Punjab, 147004, India.
3 Biotech. 2016 Dec;6(2):248. doi: 10.1007/s13205-016-0569-5. Epub 2016 Nov 17.
Xanthine oxidase is a key enzyme responsible for hyperuricemia, a pre-disposing factor for Gout and oxidative stress-related diseases. Only two clinically approved xanthine oxidase inhibitors Allopurinol and Febuxostat are currently used for treatment of hyperuricemia. However, owing to their side effects there is a need for new non-purine-based selective inhibitors of xanthine oxidase. In the process of exploring novel xanthine oxidase inhibitors and anti-oxidants, we screened the culture filtrate of 07 novel species of Muscodor, a sterile endophytic fungi isolated from Cinnamomum and Aegle marmelos. Chloroform extract of M. darjeelingensis exhibited the maximum xanthine oxidase inhibition in the qualitative and quantitative assays. The IC of chloroform extract of M. darjeelingensis was 0.54 µg/ml which was much lower to Allopurinol but higher when compared to Febuxostat. 88% reduction in uric acid production was recorded by M. darjeelingensis chloroform extract which was similar to allopurinol. The maximum anti-oxidant activity was exhibited by M. indica against the gallic acid standard in the DPPH-free radical assay. Anti-oxidant activity index of M. indica was 7.7, which was followed by M. kashayum with 5.4. M. darjeelingensis exhibited a moderate anti-oxidant activity with anti-oxidant activity index of 1.63 in the DPPH assay. The present study is the very first report of Muscodor species exhibiting xanthine oxidase inhibitory and anti-oxidant activity together. Chloroform extract of M. darjeelingensis and M. indica stand out as potential candidates for isolation and characterization of the xanthine oxidase inhibitor and anti-oxidant compound, respectively.
黄嘌呤氧化酶是导致高尿酸血症的关键酶,高尿酸血症是痛风和氧化应激相关疾病的一个诱发因素。目前仅有两种临床批准的黄嘌呤氧化酶抑制剂——别嘌醇和非布司他用于治疗高尿酸血症。然而,由于它们的副作用,需要新型的非嘌呤类黄嘌呤氧化酶选择性抑制剂。在探索新型黄嘌呤氧化酶抑制剂和抗氧化剂的过程中,我们筛选了从樟属植物和木苹果中分离出的7种无菌内生真菌——麝香霉属的培养滤液。大吉岭麝香霉的氯仿提取物在定性和定量试验中表现出最大的黄嘌呤氧化酶抑制作用。大吉岭麝香霉氯仿提取物的半数抑制浓度为0.54微克/毫升,该数值远低于别嘌醇,但高于非布司他。大吉岭麝香霉氯仿提取物使尿酸生成减少了88%,这与别嘌醇相似。在二苯基苦味酰基自由基(DPPH)试验中,印度麝香霉对没食子酸标准品表现出最大的抗氧化活性。印度麝香霉的抗氧化活性指数为7.7,其次是卡西麝香霉,为5.4。在DPPH试验中,大吉岭麝香霉表现出中等抗氧化活性,抗氧化活性指数为1.63。本研究是关于麝香霉属物种同时表现出黄嘌呤氧化酶抑制活性和抗氧化活性的首次报道。大吉岭麝香霉和印度麝香霉的氯仿提取物分别作为分离和鉴定黄嘌呤氧化酶抑制剂和抗氧化化合物的潜在候选物而脱颖而出。